Leukotriene synthesis during respiratory syncytial virus bronchiolitis: Influence of age and atopy

Pediatric Pulmonology

Volumn 40, Issue 4, 2005, Pages 285-291

  Piedimonte, Giovanni ^a,c   Renzetti, Gabriele ^a   Auais, Alexander ^a   Di Marco, Antonio ^b   Tripodi, Salvatore ^b   Colistro, Franco ^b   Villani, Alberto ^b   Di Ciommo, Vincenzo ^b   Cutrera, Renato ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c Batchelor Children's Research Institute   (United States)

Author keywords

Asthma; Eicosanoids; Leukotriene E4; Leukotriene modifiers

Indexed keywords

LEUKOTRIENE; LEUKOTRIENE E4; TOBACCO SMOKE;

ARTICLE; ASTHMA; ATOPY; BREAST FEEDING; BRONCHIOLITIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FAMILY SIZE; FEMALE; HUMAN; INFANT; MALE; PASSIVE SMOKING; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; URINALYSIS;

AGE FACTORS; ASTHMA; BRONCHIOLITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERSENSITIVITY; INFANT; LEUKOTRIENE E4; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TOBACCO SMOKE POLLUTION;

EID: 26444442535     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20285     Document Type: Article

References (34)

1. Wohl ME. Bronchiolitis. In: Chernick V, Boat TF, editors. Kendig's disorders of the respiratory tract in children. 6th ed. Philadelphia: W.B. Saunders Co.; 1998. pp 473-485.
2. Stein RT, Sherril D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545.
3. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Cell Mol Biol 2000; 161:1501-1507.
4. Piedimonte G. Origins of reactive airways disease in early life: do viral infections play a role? Acta Paediatr [Suppl] 2002;91: 6-11.
5. Piedimonte G, Simoes EA. Respiratory syncytial virus and subsequent asthma: one step closer to unravelling the Gordian knot? Eur Respir J 2002;20:515-517.
6. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med 1996;150:1166-1172.
7. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2000;2: CD001266.
8. Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 1996;348:292-295.
9. Klassen TP, Sutcliffe T, Watters LK, Wells GA, Allen UD, Li MM. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr 1997;130: 191-196.
10. Bulow SM, Nir M, Levin E, Friis B, Thomsen LL, Nielsen JE, Holm JC, Moller T, Bonde-Hansen ME, Nielsen HE. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999; 104:77.
11. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr 1998;132:849-853.
12. Fox GF, Everard ML, Marsh MJ, Milner AD. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child 1999;80:343-347.
13. Cade A, Brownlee KG, Conway SP, Haigh D, Short A, Brown J, Dassu D, Mason SA, Phillips A, Eglin R, Graham M, Chetcuti A, Chatrath M, Hudson N, Thomas A, Chetcuti PA. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000;82: 126-130.
14. Behera AK, Kumar M, Matsuse H, Lockey RF, Mohapatra SS. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 1998;251:704-709.
15. Wedde-Beer K, Hu C, Rodriguez MM, Piedimonte G. Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus. Am J Physiol 2002;282: 1143-1150.
16. Volovitz B, Welliver RC, De Castro G, Krystofik D, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988;24:504-507.
17. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC Jr., Welliver RC. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999;103:630-636.
18. Salvi SS, Krishna MT, Sampson AP, Holgate ST. The antiinflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 2001;119:1533-1546.
19. Kumlin M, Dahlen SE. Characteristics of formation and further metabolism of leukotrienes in the chopped human lung. Biochim Biophys Acta 1990;1044:201-210.
20. Kumlin M, Stensvad F, Larsson L, Dahlen B, Dahlen SE. Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans. Clin Exp Allergy 1995;25:467-479.
21. Zar JH. Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall, Inc.; 1984.
22. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
23. Maclouf J, Antoine C, De Caterina R, Sicari R, Murphy R, Patrignani P, Loizzo S, Patrono C. Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects. Am J Physiol 1992;263:244-249.
24. Huber M, Muller J, Leier I, Jedlitschky G, Ball HA, Moore KP, Taylor GW, Williams R, Keppler D. Metabolism of cysteinyl leukotrienes in monkey and man. Eur J Biochem 1990;194:309-315.
25. Tortorolo L, Langer A, Polidori G, Vento G, Stampachiacchere B, Aloe L. Piedimonte G. Neurotrophins over-expression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 2005;172:233-237.
26. Sznajer Y, Westcott JY, Wenzel SE, Mazer B, Tucci M, Toledano BJ. Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis. J Pediatr 2004;145:115-118.
27. Takahashi Y, Ichikawa M, Nawate M, Kamoshida H, Shikano T. Clinical evaluation of urinary leukotriene e4 levels in children with respiratory syncytial virus infection. Arerugi 2003;52:1132-1137.
28. Oommen A, Grigg J. Urinary leukotriene E4 in preschool children with acute clinical viral wheeze. Eur Respir J 2003;21:149-154.
29. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999;353:196-200.
30. Hu C, Wedde-Beer K, Auais A, Rodriguez MM, Piedimonte G. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol 2002;283:494-502.
31. Piedimonte G. The contribution of neuro-immune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr Infect Dis J 2003;22:66-75.
32. Piedimonte G. The association between respiratory syncytial virus infection and reactive airway disease. Respir Med [Suppl] 2002;96:26-30.
33. Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-383.
34. Bisgaard H. Montelukast in RSV-bronchiolitis. Am J Respir Crit Care Med 2004;169:542-543.